Industry News
The latest medical device regulatory news, clinical trials, and market insights
Marketecture Media Secures $1M Seed Round to Accelerate B2B Marketing Expansion
Meta Description: Marketecture Media has closed a $1 million seed funding round from leading advertising industry investors, fueling growth and…
Pharma Leaders Eye Multi-Billion Acquisitions as 2026 M&A Climate Shifts
Meta description: Healthcare executives and investors signal readiness for large-scale mergers and acquisitions in 2026 amid eased regulatory barriers and…
EpiBiologics Secures $107M Series B Led by J&J and Google Ventures for Protein Degradation Expansion
Meta description: EpiBiologics raises $107 million in Series B funding led by Johnson & Johnson’s and Google Ventures’ investment arms,…
Mediar Secures $76 Million Series B to Advance Fibrosis Clinical Programs
Meta description: Mediar Therapeutics raises $76 million in Series B funding to push multiple anti-fibrotic drug candidates through Phase IIa…
GSME Raises $35M Series B to Advance AI and Semiconductor Services
Meta description: GS Microelectronics secures $35 million Series B funding led by Maverick Silicon to expand AI-driven chip design and…
Shrinking Acquisition Pool in Medical Devices Signals Risk for Startup Innovation
Meta description: Consolidation in the medical device sector is limiting acquisition opportunities for startups, raising concerns for investors and long-term…
Apella Raises $80 Million to Scale Ambient AI in Hospitals
Meta description: Apella secures $80 million in Series B funding to expand its ambient AI hospital platform, backed by major…
Major Medical Devices Gains Strategic Backing to Accelerate AAA Repair System Commercialization
Meta Description: Major Medical Devices secures a key strategic investment from TCA Venture Group to fast-track its next-generation abdominal aortic…
Regulatory Update: Swissmedic Expands Therapeutic Indication for Jaypirca®
Swissmedic has announced an extension of the therapeutic indication for Jaypirca®, a development that could impact clinical practice and regulatory…
Swissmedic Announces Recall of Ringerfundin B. Braun Batch Due to Quality Issues
On January 10, 2026, Swissmedic issued an official recall notice regarding specific batches of Ringerfundin B. Braun Infusionslösung. This recall…
Swissmedic Announces Recall of Specific Batches of Esomeprazol MUT Sandoz Tablets
On January 10, 2026, Swissmedic issued an announcement concerning the recall of designated batches of Esomeprazol MUT Sandoz gastro-resistant tablets.…
Swissmedic Expands Therapeutic Indication Approval for Pemazyre®
Swissmedic, the Swiss agency responsible for the authorisation and supervision of therapeutic products, recently approved an extension for the therapeutic…